Publisher
Springer International Publishing
Reference104 articles.
1. Sulzberger MB, Witten VH. Effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19:101–2.
2. Feldman SR. The biology and clinical application of systemic corticosteroids. In: Callan JP, editor. Current problems in dermatology. St. Louis: Mosby-Year Book; 1992. p. 211–35.
3. Schacke H, Schottelius A, Docke WD, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A. 2004;101:227–32.
4. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96:23–43.
5. Heck S, Bender K, Kullmann M, et al. I kap- paB alpha-independent downregulation of NF-kap- paB activity by glucocorticoid receptor. EMBO J. 1997;16:4698–707.